Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Sulindac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for sulindac?

Sulindac is the generic ingredient in two branded drugs marketed by Epic Pharma, Merck, Sandoz, Mylan, Sun Pharm Inds, Heritage Pharms Inc, Ani Pharms Inc, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sulindac. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: sulindac

Tradenames:2
Patents:1
Applicants:8
NDAs:13
Drug Master File Entries: see list14
Suppliers / Packagers: see list21
Bulk Api Vendors: see list42
Clinical Trials: see list14
Patent Applications: see list9,926
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sulindac at DailyMed

Pharmacology for Ingredient: sulindac

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma
SULINDAC
sulindac
TABLET;ORAL072711-001Mar 25, 1991RXNoNo► Subscribe► Subscribe
Merck
CLINORIL
sulindac
TABLET;ORAL017911-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Heritage Pharms Inc
SULINDAC
sulindac
TABLET;ORAL073262-002Sep 6, 1991RXNoNo► Subscribe► Subscribe
Epic Pharma
SULINDAC
sulindac
TABLET;ORAL072710-001Mar 25, 1991RXNoNo► Subscribe► Subscribe
Watson Labs
SULINDAC
sulindac
TABLET;ORAL071891-001Apr 3, 1990RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sulindac

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
CLINORIL
sulindac
TABLET;ORAL017911-001Approved Prior to Jan 1, 19823,654,349► Subscribe
Merck
CLINORIL
sulindac
TABLET;ORAL017911-002Approved Prior to Jan 1, 19823,725,548► Subscribe
Merck
CLINORIL
sulindac
TABLET;ORAL017911-001Approved Prior to Jan 1, 19823,725,548► Subscribe
Merck
CLINORIL
sulindac
TABLET;ORAL017911-002Approved Prior to Jan 1, 19823,654,349► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc